Writing an IND Module 3 for Cell and Gene Therapy Products: Considerations and Challenges

In the European Union (EU), gene therapy medicinal products (GTMP) are a subset of advanced therapy medicinal products (ATMPs) and may consist of or contain genetically modified organisms (GMOs). The EU GMO frameworks were developed to address environmental concerns related to GMOs for agricultural use.

Please enter your details to get access to the resource








    This site uses cookies to personalize and customize your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

    Privacy Settings saved!
    Privacy Settings

    When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.


    • wordpress_test_cookie
    • wordpress_logged_in_
    • wordpress_sec

    Decline all Services
    Accept all Services
    Secured By miniOrange